BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 34710372)

  • 21. Neurometals in the Pathogenesis of Prion Diseases.
    Kawahara M; Kato-Negishi M; Tanaka KI
    Int J Mol Sci; 2021 Jan; 22(3):. PubMed ID: 33525334
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A seven-residue deletion in PrP leads to generation of a spontaneous prion formed from C-terminal C1 fragment of PrP.
    Munoz-Montesino C; Larkem D; Barbereau C; Igel-Egalon A; Truchet S; Jacquet E; Nhiri N; Moudjou M; Sizun C; Rezaei H; Béringue V; Dron M
    J Biol Chem; 2020 Oct; 295(41):14025-14039. PubMed ID: 32788216
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Monoacylated cellular prion protein modifies cell membranes, inhibits cell signaling, and reduces prion formation.
    Bate C; Williams A
    J Biol Chem; 2011 Mar; 286(11):8752-8. PubMed ID: 21212283
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Sialylation of prion protein controls the rate of prion amplification, the cross-species barrier, the ratio of PrPSc glycoform and prion infectivity.
    Katorcha E; Makarava N; Savtchenko R; D'Azzo A; Baskakov IV
    PLoS Pathog; 2014 Sep; 10(9):e1004366. PubMed ID: 25211026
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Association of prion protein genotype and scrapie prion protein type with cellular prion protein charge isoform profiles in cerebrospinal fluid of humans with sporadic or familial prion diseases.
    Schmitz M; Lüllmann K; Zafar S; Ebert E; Wohlhage M; Oikonomou P; Schlomm M; Mitrova E; Beekes M; Zerr I
    Neurobiol Aging; 2014 May; 35(5):1177-88. PubMed ID: 24360565
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Amino acid sequence and prion strain specific effects on the in vitro and in vivo convertibility of ovine/murine and bovine/murine prion protein chimeras.
    Kupfer L; Eiden M; Buschmann A; Groschup MH
    Biochim Biophys Acta; 2007 Jun; 1772(6):704-13. PubMed ID: 17145171
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Molecular interaction between prion protein and GFAP both in native and recombinant forms in vitro.
    Dong CF; Wang XF; Wang X; Shi S; Wang GR; Shan B; An R; Li XL; Zhang BY; Han J; Dong XP
    Med Microbiol Immunol; 2008 Dec; 197(4):361-8. PubMed ID: 18087720
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The Size and Stability of Infectious Prion Aggregates Fluctuate Dynamically during Cellular Uptake and Disaggregation.
    Shoup D; Priola SA
    Biochemistry; 2021 Feb; 60(5):398-411. PubMed ID: 33497187
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Assessment of the PrPc Amino-Terminal Domain in Prion Species Barriers.
    Davenport KA; Henderson DM; Mathiason CK; Hoover EA
    J Virol; 2016 Dec; 90(23):10752-10761. PubMed ID: 27654299
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prion proteins: a biological role beyond prion diseases.
    Hu W; Rosenberg RN; Stüve O
    Acta Neurol Scand; 2007 Aug; 116(2):75-82. PubMed ID: 17661791
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Molecular biology and pathology of prion strains in sporadic human prion diseases.
    Gambetti P; Cali I; Notari S; Kong Q; Zou WQ; Surewicz WK
    Acta Neuropathol; 2011 Jan; 121(1):79-90. PubMed ID: 21058033
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The metabolism of glycosaminoglycans is impaired in prion diseases.
    Mayer-Sonnenfeld T; Zeigler M; Halimi M; Dayan Y; Herzog C; Lasmezas CI; Gabizon R
    Neurobiol Dis; 2005 Dec; 20(3):738-43. PubMed ID: 15951190
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Allelic Interference in Prion Replication Is Modulated by the Convertibility of the Interfering PrP
    Espinosa JC; Andreoletti O; Marín-Moreno A; Lugan S; Aguilar-Calvo P; Cassard H; Lorenzo P; Douet JY; Villa-Díaz A; Aron N; Prieto I; Huor A; Torres JM
    mBio; 2021 Mar; 12(2):. PubMed ID: 33727358
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Mechanisms of prion transmission].
    Sakaguchi S
    Nihon Rinsho; 2007 Aug; 65(8):1391-5. PubMed ID: 17695274
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Transmission characteristics of heterozygous cases of Creutzfeldt-Jakob disease with variable abnormal prion protein allotypes.
    Ward A; Hollister JR; McNally K; Ritchie DL; Zanusso G; Priola SA
    Acta Neuropathol Commun; 2020 Jun; 8(1):83. PubMed ID: 32517816
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Sheep scrapie susceptibility-linked polymorphisms do not modulate the initial binding of cellular to disease-associated prion protein prior to conversion.
    Rigter A; Bossers A
    J Gen Virol; 2005 Sep; 86(Pt 9):2627-2634. PubMed ID: 16099922
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The octarepeat region of the prion protein is conformationally altered in PrP(Sc).
    Yam AY; Gao CM; Wang X; Wu P; Peretz D
    PLoS One; 2010 Feb; 5(2):e9316. PubMed ID: 20195363
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Region-Specific Sialylation Pattern of Prion Strains Provides Novel Insight into Prion Neurotropism.
    Makarava N; Chang JC; Baskakov IV
    Int J Mol Sci; 2020 Jan; 21(3):. PubMed ID: 32012886
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prion protein (PrP) with amino-proximal deletions restoring susceptibility of PrP knockout mice to scrapie.
    Fischer M; Rülicke T; Raeber A; Sailer A; Moser M; Oesch B; Brandner S; Aguzzi A; Weissmann C
    EMBO J; 1996 Mar; 15(6):1255-64. PubMed ID: 8635458
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Uptake and degradation of protease-sensitive and -resistant forms of abnormal human prion protein aggregates by human astrocytes.
    Choi YP; Head MW; Ironside JW; Priola SA
    Am J Pathol; 2014 Dec; 184(12):3299-307. PubMed ID: 25280631
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.